News Releases

April 2021

April 2, 2021 4/2/2021 CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine

April 1, 2021 4/1/2021 Takeda Hosts Wave 1 Pipeline Market Call

April 1, 2021 4/1/2021 Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma Limited

March 2021

March 31, 2021 3/31/2021 Takeda Completes Sale of Select OTC and Non-Core Assets to Orifarm

March 31, 2021 3/31/2021 Takeda Announces Candidates for New Directors

March 31, 2021 3/31/2021 Takeda Completes Sale of its Japan Consumer Health Care Business Unit to Blackstone

March 25, 2021 3/25/2021 Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

March 15, 2021 3/15/2021 Subgroup Analysis from Phase 3 Clinical Trial Supports Efficacy of Maribavir Over Conventional Therapies in Transplant Recipients With Cytomegalovirus Infection

March 15, 2021 3/15/2021 Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine